COVID-19 환자에서 나타나는 섬망에 대한 고찰

키워드

참고문헌 (62)

1. "WHO Director-General’s opening remarks at the media briefing on COVID-19—11 March 2020"[URL]
2. Cao Z, "Clinical characteristics of coronavirus disease 2019 patients in Beijing, China", PLoS One, 15, pp.e0234764~ (2020)
3. Stokes EK, "Coronavirus disease 2019 case surveillance -United States, January 22-May 30, 2020", MMWR Morb Mortal Wkly Rep, 69, pp.759~765 (2020)
4. Mao L, "Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China", JAMA Neurol, 77, pp.683~690 (2020)
5. Montalvan V, "Neurological manifestations of COVID-19 and other coronavirus infections : a systematic review", Clin Neurol Neurosurg, 194, pp.105921~ (2020)
6. Rogers JP, "Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections : a systematic review and metaanalysis with comparison to the COVID-19 pandemic", Lancet Psychiatry, 7, pp.611~627 (2020)
7. Orsini A, "Challenges and management of neurological and psychiatric manifestations in SARS-CoV-2(COVID-19)patients", Neurol Sci, 41, pp.2353~2366 (2020)
8. Helms J, "Delirium and encephalopathy in severe COVID-19 : a cohort analysis of ICU patients", Crit Care, 24, pp.491~ (2020)
9. Benussi A, "Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy", Neurology, 95, pp.e910~e920 (2020)
10. Kennedy M, "Delirium in older patients with COVID-19 presenting to the emergency department", JAMA Netw Open, 3, pp.e2029540~ (2020)
11. Tay HS, "Atypical presentation of COVID-19 in a frail older person", Age Ageing, 49, pp.523~524 (2020)
12. Alkeridy WA, "A unique presentation of delirium in a patient with otherwise asymptomatic COVID-19", J Am Geriatr Soc, 68, pp.1382~1384 (2020)
13. McMichael TM, "Epidemiology of Covid-19 in a long-term care facility in King County, Washington", N Engl J Med, 382, pp.2005~2011 (2020)
14. Pilotto A, "COVID-19 impact on consecutive neurological patients admitted to the emergency department", J Neurol Neurosurg Psychiatry, 92, pp.218~220 (2021)
15. Jäckel M, "Is delirium a specific complication of viral acute respiratory distress syndrome?", Crit Care, 24, pp.401~ (2020)
16. Helms J, "Neurologic features in severe SARS-CoV-2 infection", N Engl J Med, 382, pp.2268~2270 (2020)
17. Garcez FB, "Delirium and adverse outcomes in hospitalized patients with COVID-19", J Am Geriatr Soc, 68, pp.2440~2446 (2020)
18. Ticinesi A, "Delirium in COVID-19 : epidemiology and clinical correlations in a large group of patients admitted to an academic hospital", Aging Clin Exp Res, 32, pp.2159~2166 (2020)
19. Kremer S, "Neurologic and neuroimaging findings in patients with COVID-19 : a retrospective multicenter study", Neurology, 95, pp.e1868~e1882 (2020)
20. Zerah L, "Clinical characteristics and outcomes of 821 older patients with SARS-Cov-2 infection admitted to acute care geriatric wards : a multicenter retrospective cohort study", J Gerontol A Biol Sci Med Sci, 76, pp.e4~e12 (2021)
21. Knopp P, "Presenting features of COVID-19 in older people: relationships with frailty, inflammation and mortality", Eur Geriatr Med, 11, pp.1089~1094 (2020)
22. De Smet R, "Frailty and mortality in hospitalized older adults with COVID-19 : retrospective observational study", J Am Med Dir Assoc, 21, pp.928~932.e1 (2020)
23. Hawkins M, "A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19", J Psychosom Res, 141, pp.110350~ (2021)
24. Kotfis K, "COVID-19 : ICU delirium management during SARSCoV-2 pandemic", Crit Care, 24, pp.176~ (2020)
25. Li YC, "The neuroinvasive potential of SARSCoV2may play a role in the respiratory failure of COVID-19 patients", J Med Virol, 92, pp.552~555 (2020)
26. Karuppan MKM, "SARS-CoV-2 infection in the central and peripheral nervous system-associated morbidities and their potential mechanism", Mol Neurobiol, 58, pp.2465~2480 (2021)
27. Khan S, "Neuropathogenesis of SARS-CoV-2 infection", Elife, 30, pp.e59136~ (2020)
28. Huang YH, "SARS-CoV-2 detected in cerebrospinal fluid by PCR in a case of COVID-19 encephalitis", Brain Behav Immun, 87, pp.149~ (2020)
29. Saleki K, "The involvement of the central nervous system in patients with COVID-19", Rev Neurosci, 31, pp.453~456 (2020)
30. Roy D, "Neurological and neuropsychiatric impacts of COVID-19 pandemic", Can J Neurol Sci, 48, pp.9~24 (2021)
31. Tabary M, "Pathologic features of COVID-19 : a concise review", Pathol Res Pract, 216, pp.153097~ (2020)
32. von Bohlen Und Halbach O, "The angiotensin converting enzyme 2(ACE2)system in the brain : possible involvement in Neuro-Covid", Histol Histopathol, 18, pp.18356~ (2021)
33. Iroegbu JD, "Potential neurological impact of coronaviruses : implications for the novel SARS-CoV-2", Neurol Sci, 41, pp.1329~1337 (2020)
34. Pallanti S, "Importance of SARs-Cov-2 anosmia : from phenomenology to neurobiology", Compr Psychiatry, 100, pp.152184~ (2020)
35. Saussez S, "Anosmia : an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered", Eur Arch Otorhinolaryngol, 278, pp.2187~2191 (2021)
36. Chigr F, "Comment on"the neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients"", J Med Virol, 92, pp.703~704 (2020)
37. Jain U, "Effect of COVID-19 on the organs", Cureus, 12, pp.e9540~ (2020)
38. Cunningham C, "Systemic inflammation and delirium : important co-factors in the progression of dementia", Biochem Soc Trans, 39, pp.945~953 (2011)
39. Schreuder L, "Pathophysiological and behavioral effects of systemic inflammation in aged and diseased rodents with relevance to delirium : a systematic review", Brain Behav Immun, 62, pp.362~381 (2017)
40. Perrin P, "Cytokine release syndrome-associated encephalopathy in patients with COVID-19", Eur J Neurol, 28, pp.248~258 (2021)
41. Soy M, "Cytokine storm in COVID-19 : pathogenesis and overview of antiinflammatory agents used in treatment", Clin Rheumatol, 39, pp.2085~2094 (2020)
42. De Santis G, "SARS-CoV-2 : a new virus but a familiar inflammation brain pattern", Brain Behav Immun, 87, pp.95~96 (2020)
43. Fotuhi M, "Neurobiology of COVID-19", J Alzheimers Dis, 76, pp.3~19 (2020)
44. Han MI, "Clinical approach to delirium in elderly patients", J Korean Geriatr Psychiatry, 8, pp.96~101 (2004)
45. Marcantonio ER, "Delirium in hospitalized older adults", N Engl J Med, 377, pp.1456~1466 (2017)
46. Baller EB, "Neurocovid : pharmacological recommendations for delirium associated with COVID-19", Psychosomatics, 61, pp.585~596 (2020)
47. di Giacomo E, "Management of older people during the COVID-19 outbreak : recommendations from an Italian experience", Int J Geriatr Psychiatry, 35, pp.803~805 (2020)
48. Radhakrishnan NS, "Implementing delirium prevention in the era of COVID-19", J Alzheimers Dis, 79, pp.31~36 (2021)
49. LaHue SC, "Collaborative delirium prevention in the age of COVID-19", J Am Geriatr Soc, 68, pp.947~949 (2020)
50. Castro REV, "Patient care during the COVID-19 pandemic : do not leave delirium behind", Braz J Psychiatry, 43, pp.127~128 (2021)
51. O’Hanlon S, "Delirium : a missing piece in the COVID-19pandemic puzzle", Age Ageing, 49, pp.497~498 (2020)
52. Pun BT, "Prevalence and risk factors for delirium in critically ill patients with COVID-19(COVID-D) : a multicentre cohort study", Lancet Respir Med, 9, pp.239~250 (2021)
53. National Institute for Health and Care Excellence (NICE) in collaboration with NHS England and NHS Improvement, "Managing COVID-19 symptoms (including at the end of life) in the community:summary of NICE guidelines", BMJ, 369, pp.m1461~ (2020)
54. Sher Y, "COVID-19–associated hyperactive intensive care unit delirium with proposed pathophysiology and treatment : a case report", Psychosomatics, 61, pp.544~550 (2020)
55. Zhang R, "COVID-19 : melatonin as a potential adjuvant treatment", Life Sci, 250, pp.117583~ (2020)
56. Wichniak A, "Melatonin as a potential adjuvant treatment for COVID-19 beyond sleep disorders", Int J Mol Sci, 22, pp.8623~ (2021)
57. Fontaine GV, "Melatonin, ramelteon, suvorexant, and dexmedetomidine to promote sleep and prevent delirium in critically ill patients: a narrative review with practical applications", Crit Care Nurs Q, 43, pp.232~250 (2020)
58. Cardinali DP, "Elderly as a high-risk group during COVID-19 pandemic: effect of circadian misalignment, sleep dysregulation and melatonin administration", Sleep Vigil (2020)
59. Ostuzzi G, "Safety of psychotropic medications in people with COVID-19 : evidence review and practical recommendations", BMC Med, 18, pp.215~ (2020)
60. Martinotti G, "Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg", 1.3 ml immediate release, 2020, pp.237, 3497~3501
61. Anmella G, "COVID-19 inpatients with psychiatric disorders : real-world clinical recommendations from an expert team in consultation-liaison psychiatry", J Affect Disord, 274, pp.1062~1067 (2020)
62. Sanders BJ, "Hyperactive delirium requires more aggressive management in patients with COVID-19 : temporarily rethinking"low and slow"", J Pain Symptom Manage, 60, pp.e31~e32 (2020)

관련 논문AI추천